Overcoming challenges in market access of generic medicines in the European Union

Journal of Generic Medicines

Volumn 9, Issue 1, 2012, Pages 21-28

  Dylst, Pieter ^a   Vulto, Arnold ^b   Simoens, Steven ^a  

^a Research Centre for Pharmaceutical Care and Pharmaco Economics   (Belgium)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

data protection; Europe; generic medicines; Market access; marketing authorisation; marketing exclusivity; pricing; reimbursement

Indexed keywords

GENERIC DRUG;

DRUG APPROVAL; DRUG COST; DRUG EFFICACY; DRUG LEGISLATION; DRUG MARKETING; DRUG QUALITY; DRUG SAFETY; EUROPEAN UNION; GOVERNMENT REGULATION; REIMBURSEMENT; REVIEW; RISK BENEFIT ANALYSIS;

EID: 84871771397     PISSN: 17411343     EISSN: 17417090     Source Type: Journal    
DOI: 10.1177/1741134312441107     Document Type: Review

References (29)

1. Sheppard A. Generic medicines: essential contributors to the long-term health of society. Sector sustainability challenges in Europe. 2010. London, United Kingdom: IMS.
2. European Commission. Directive 2004/27/EC of the European Parliament and of the Council of 31st March 2004 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use. Official Journal of the European Union L 136/34-57, 2004. Brussels, Belgium: European Commission.
3. Simoens S and De Coster S. Sustaining generic medicines markets in Europe. Report, Katholieke Universiteit Leuven, Leuven, Belgium, 2006.
4. Sollano JA, Kirsch JM, Bala MV, et al. The economics of drug discovery and the ultimate valuation of pharmacotherapies in the marketplace. Clin Pharmacol Ther. 2008 ; 84 (2). 263-266
5. European Commission. Pharmaceutical sector inquiry. Final report. 2009. Brussels, Belgium: European Commission.
6. European Generic Medicines Association. Pharmaceutical patents. Brussels, Belgium: European Generic Medicines Association. www.egagenerics.com (2010, accessed 3 August 2011).
7. Cullen D. Data protection: the new IP frontier - an overview of existing laws and regulations. J Generic Med. 2007 ; 5 (1). 9-25
8. Convention on the grant of European patents (European patent convention). 14 th edn. Munich, Germany: European Patent Office, 2010. Munich, Germany: European Patent Office ; 2010 :
9. European Generic Medicines Association. Patent-related barriers to market entry for generic medicines in the European Union. A review of weaknesses in the current European patent system and their impact on the market access of generic medicines. 2008. Brussels, Belgium: European Generic Medicines Association.
10. European Commission. Council Regulation (EEC) No 1768/92 of 18 June 1992 concerning the creation of a supplementary protection certificate for medicinal products. 1992. Brussels, Belgium: European Commission.
11. European Commission. Regulation (EC) 1901/2006 of the European Parliament and of the Council of 12th December 2006 on medicinal products for paediatric use and amending Regulation (EEC) 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) 726/2004. 2006. Brussels, Belgium: European Commission.
12. Simoens S. Developing competitive and sustainable polish generic medicines market. Croation Med J. 2009 ; 50: 440-448
13. Horgan J. Supplementary Protection Certificates (SPCs) and data exclusivity in Europe. 2008. London, UK: European Patent Department, Merck & Co., Inc.
14. Haraldsdóttir H. Community referrals - opportunities for improvements. J Generic Med. 2010 ; 7: 243-261
15. Anonymous. Registration procedures for generic drugs in the EU. Belgium: GaBi Online: Generic and Biosimilars Initiative. http://www.gabionline.net/ Reports/Registration-procedures-for-generic-drugs-in-the-EU (2011, accessed 5 August 2011).
16. European Commission. Council Directive 89/105/EEC of 21 December 1989 relating to the transparency of measures regulating the pricing of medicinal products for human use and their inclusion in the scope of national health insurance systems (the 'Transparency Directive'). 1989. Brussels, Belgium: European Commission.
17. European Generic Medicines Association. How to increase patient access to generic medicines in European healthcare systems. 2009. Brussels, Belgium: European Generic Medicines Association.
18. Pope Benedictus XVI. Caritas in Veritate. Encyclical Letter. June 29 2009.
19. Anonymous. Portugal is the plaything of originators' dirty tricks. Generics Bulletin, 10 June 2011, pp. 32-33.
20. Tuominen N. Defensive patent protection strategies in the pharmaceutical industry - a response to a legal problem?. Bruges Campus, Law Department, College of Europe, 2010.
21. Kesselheim A. Intellectual property policy in the pharmaceutical sciences: the effect of inappropriate patents and market exclusivity extensions on the health care system. AAPS J. 2007 ; 9 (3). E306 - E311
22. Rathod SK. Ever-greening: a status check in selected countries. J Generic Med. 2010 ; 7 (3). 227-242
23. Anonymous. Italy is turning the corner after reference-price cuts. Generics Bulletin, 10 June 2011, pp. 36-37.
24. GaBi. Italy asked to comply with marketing rules for generics. 2012. Belgium: GaBi Online: Generic and Biosimilars Initiative. http://www.gabionline. net/layout/set/print/Generics/News/Italy-asked-to-comply-with-marketing-rules- for-generics (2012, accessed 3 February 2012).
25. European Generic Medicines Association. 2011 market review. 2011. Brussels, Belgium: European Generic Medicines Association.
26. Anonymous. A deal to get cheaper and safer drugs. New York Times, August 17 2011.
27. Annemans L, Cleemput I, Hustaert F, et al. Stimulating pharmaceutical innovation in the EU. Expert Rev Pharmacoecon Outcomes Res. 2011 ; 11 (3). 235-239
28. Annemans L, Arickx F, Belle O, et al. A call to make valuable innovative medicines available in the European Union. Background report for the ministerial conference 'Innovation and solidarity on pharmaceuticals'. 2010. Brussels, Belgium: RIZIV.
29. European Patent Office. Unitary patent/EU patent. 2012. Munich, Germany: European Patent Office. http://www.epo.org/law-practice/legislative-initiatives/ eu-patent.html (2012, accessed 31 January 2012).